Serum Complement C4 Levels Are a Useful Biomarker for Predicting End-Stage Renal Disease in Microscopic Polyangiitis
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms241914436 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Shogo Matsuda und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine IV, Division of Rheumatology, Osaka Medical and Pharmaceutical University, Osaka 569-8686, Japan. Hauptthemen laut MEDLINE: Microscopic Polyangiitis, Kidney Failure, Chronic. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This study aimed to evaluate the risk factors for end-stage renal disease (ESRD) in microscopic polyangiitis (MPA). In total, 74 patients with MPA were enrolled, and we compared the baseline clinical characteristics and disease activity between MPA patients who have progressed to ESRD and those without ESRD to select predictive factors for ESRD. Out of 74 patients, 12 patients (16.2%) had ESRD during follow-up. Serum C4 levels were significantly higher in MPA patients who have progressed to ESRD than in those without ESRD (p = 0.009). Multivariate analyses revealed that high serum creatinine levels (odds ratio (OR) 4.4, 95% confidence interval (CI) 1.25–15.5) and high serum C4 levels (OR 1.24, 95% CI 1.03–1.49) were risk factors for ESRD. Using receiver operating characteristic analysis, the cut-off value for initial serum C4 levels and serum creatinine levels were 29.6 mg/dL and 3.54 mg/dL, respectively. Patients with MPA with a greater number of risk factors (serum C4 levels > 29.6 mg/dL and serum creatinine levels > 3.54 mg/dL) had a higher ESRD progression rate. Serum C4 levels were significantly positively correlated with serum creatinine levels and kidney Birmingham vasculitis activity score (p = 0.02 and 0.04, respectively). These results suggest that serum C4 levels are useful tools for assessing renal disease activity and prognosis in MPA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine IV, Division of Rheumatology, Osaka Medical and Pharmaceutical University, Osaka 569-8686, Japan.
ORCID-Profile: Hideyuki Shiba
Zitieren
APA
Matsuda, S., Oe, K., Kotani, T., Okazaki, A., Kiboshi, T., Suzuka, T., Wada, Y., Shiba, H., Hata, K., Shoda, T., & Takeuchi, T. (2023). Serum Complement C4 Levels Are a Useful Biomarker for Predicting End-Stage Renal Disease in Microscopic Polyangiitis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241914436
Vancouver
Matsuda S, Oe K, Kotani T, Okazaki A, Kiboshi T, Suzuka T, et al. Serum Complement C4 Levels Are a Useful Biomarker for Predicting End-Stage Renal Disease in Microscopic Polyangiitis. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241914436
BibTeX
@article{Matsuda2023,
author = {Matsuda, Shogo and Oe, Katsumasa and Kotani, Takuya and Okazaki, Ayana and Kiboshi, Takao and Suzuka, Takayasu and Wada, Yumiko and Shiba, Hideyuki and Hata, Kenichiro and Shoda, Takeshi and Takeuchi, Tohru},
title = {Serum Complement C4 Levels Are a Useful Biomarker for Predicting End-Stage Renal Disease in Microscopic Polyangiitis},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms241914436}
}
EUVIMED